Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Bristol-Myers Squibb Stories

2012-08-20 23:01:48

Parker Waichman LLP has filed a lawsuit on behalf of a man who experienced hemorrhaging, allegedly due to the use of Plavix (clopidogrel). The lawsuit alleges that Plavix caused the bleeding and claims that the Defendants failed to fully inform users about the risks of taking the blood-thinning medication. New York, NY (PRWEB) August 20, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit against...

2012-08-20 02:34:43

VANCOUVER, British Columbia, Aug. 20, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Molycorp (NYSE:MCP), Brocade (NASDAQ:BRCD), Symantec (NASDAQ:SYMC), Bristol-Myers Squibb (NYSE:BMY), Ares Capital (NASDAQ:ARCC), and Best Buy (NYSE:BBY). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

2012-08-13 02:29:10

VANCOUVER, British Columbia, Aug. 13, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Cisco (NASDAQ:CSCO), Seagate (NASDAQ:STX), AT&T (NYSE:T), Oracle (NASDAQ:ORCL), Bristol Myers Squibb (NYSE:BMY), and Barrick Gold (NYSE:ABX). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

2012-08-06 06:23:57

BETHLEHEM, Pa., Aug. 6, 2012 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today the company has expanded its existing relationship with Bristol-Myers Squibb Company (NYSE: BMY) by entering into a Master Early Development Collaboration Agreement, which may include multiple feasibility studies and companion diagnostic...

2012-08-03 02:26:54

VANCOUVER, British Columbia, Aug. 3, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Bristol Myers Squibb (NYSE:BMY), Sealed Air (NYSE:SEE), Symantec (NASDAQ:SYMC), Morgan Stanley (NYSE:MS), Dow Chemical (NYSE:DOW), and Incyte (NASDAQ:INCY). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

2012-07-26 02:29:02

PARIS, July 26, 2012 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q2 2012 Change on a Change at H1 2012 Change on a Change at reported constant reported constant basis exchange rates(1) basis exchange rates ----- ---------------- ----- -------------- Net sales...

2012-07-24 10:10:48

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease. The drug rifampin, used for treating TB, can lower levels of the HIV medicine efavirenz, so the FDA recommended that patients who weigh more than 50 kg (110 pounds) and who are taking both medications should get 30...

2012-07-18 02:26:44

NEW YORK, July 18, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood-thinners, proton-pump inhibitors, antipsychotics and asthma therapeutic categories continue to remain top sellers. Top Five Drugs by Sales, Q1 2012 Drug Name Sales ($000) % Change (previous quarter) --------- ----------- ------------------...

2012-07-12 02:30:09

VANCOUVER, British Columbia, July 12, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Freeport-McMoRan (NYSE:FCX), Bristol Myers Squibb (NYSE:BMY), Ciena (NASDAQ:CIEN), Beazer Homes (NYSE:BZH), CYS (NYSE:CYS), and ADTRAN (NASDAQ:ADTN). (Logo: http://photos.prnewswire.com/prnh/20120531/HK16417LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link...

2012-07-10 22:20:59

LONDON, July 11, 2012 /PRNewswire/ -- Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1. The study demonstrated superiority of the dolutegravir-based regimen compared to the single tablet regimen Atripla®. At 48 weeks, 88% of study participants on the dolutegravir regimen were virologically suppressed (<50...